[1]
J. Zúñiga Cisneros, M. Camilleri, and M. Grover, “Glucagon-Like Peptide-1 Receptor Agonist and Gastrointestinal Adverse Effects: A Comprehensive Review”, ACTA, vol. 56, no. 3, pp. 269–288, Sep. 2026.